This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business, for the procurement of STELARA 90 MG/ML syringes. The contract has a ceiling value of $12,117.01 and a period of performance extending through November 13, 2024. Dakota Drug, Inc. has a significant single-award Indefinite Delivery Contract (IDC) with the DLA, valued at $999,999,999.00, which enables the company to provide a comprehensive range of pharmaceutical products, medical supplies, and healthcare equipment to support U.S. Armed Forces medical operations. This particular delivery order falls under the DLA Troop Support Medical's ECAT Generation V Program. The contract is not designated as a set-aside.
Generated 2/11/25, 10:05 AM